Current Cancer Therapy Reviews
Title:ACKNOWLEDGEMENTS TO REVIEWERS
Volume: 12 Issue: 4
Author(s): .
Affiliation:
Export Options
About this article
Cite this article as:
. , ACKNOWLEDGEMENTS TO REVIEWERS, Current Cancer Therapy Reviews 2016; 12 (4) . https://dx.doi.org/10.2174/157339471204170511185247
DOI https://dx.doi.org/10.2174/157339471204170511185247 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Related Books
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds
Recent Patents on Anti-Cancer Drug Discovery The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine
Current Molecular Medicine Multi-Target Directed Indole Based Hybrid Molecules in Cancer Therapy : An Up-To-Date Evidence-Based Review
Current Topics in Medicinal Chemistry Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers Aging and Inflammation: Etiological Culprits of Cancer
Current Aging Science Edelfosine: An Antitumor Drug Prototype
Anti-Cancer Agents in Medicinal Chemistry HGF/MET Signaling in Ovarian Cancer
Current Molecular Medicine EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Peptides as Tight Junction Modulators
Current Pharmaceutical Design A Perspective on Stem Cells as Biological Systems that Produce Differentiated Osteoblasts and Odontoblasts
Current Stem Cell Research & Therapy Cancer Rehabilitation: Recommendations for Integrating Exercise Programming in the Clinical Practice Setting
Current Cancer Therapy Reviews Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Rho GTPase Activating Proteins in Cancer Phenotypes
Current Protein & Peptide Science iLoc-Gpos: A Multi-Layer Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Gram-Positive Bacterial Proteins
Protein & Peptide Letters Retracted: Titanium and Vanadium Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells
Current Cancer Drug Targets Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples
Current Pharmaceutical Analysis Regulation of Ion Channels, Cellular Carriers and Na(+)/K(+)/ATPase by Janus Kinase 3
Current Medicinal Chemistry Computer Aided Drug Design Approaches to Develop Cyclooxygenase Based Novel Anti-Inflammatory and Anti-Cancer Drugs
Current Pharmaceutical Design